Research Associate I - Hematologic Malignancies

at  City Of Hope

Join the forefront of groundbreaking research at the Beckman Research Institute of City of Hope, where we’re changing lives and making a real difference in the fight against cancer, diabetes, and other life-threatening illnesses. Our dedicated and compassionate faculty and staff are driven by a common mission: Contribute to innovative approaches in predicting, preventing, and curing diseases, shaping the future of medicine through cutting-edge research.
Dr. Danilov’s laboratory investigates epigenetic mechanisms of drug resistance in hematologic malignancies.
Gene dysregulation and altered post-translational control are hallmarks of cancer. Our research focuses on the role of epigenetic dysregulation of pro-survival pathways, and how this signaling can be targeted. In addition to a variety of in vitro models of the stromal niche, our laboratory models hematologic malignancies in vivo. Dr. Danilov’s research is highly translational and involves work with primary samples from patients with hematologic malignancies. Based on laboratory findings, Dr. Danilov’s group originates early-phase clinical trials, allowing for verification of laboratory findings in the clinical setting. The lab also conducts analysis of correlative samples from patients enrolled on clinical trials.
We are seeking a highly motivated individual who values teamwork but also aspires to become a project driver.

YOUR QUALIFICATIONS SHOULD INCLUDE:

• Bachelor’s degree in biological sciences.
• 0-2 years of research/laboratory experience.
  City of Hope is an equal opportunity employer. To learn more about our commitment to diversity, equity and inclusion, please click here.
  To learn more about our Comprehensive Benefits, please CLICK HERE

Please refer the Job description for details